This note provides a high-level overview for international companies, investors and advisers considering entry into the Bangladeshi pharmaceutical and pharmacy retail market. It summarises the typical regulatory framework, commercial vehicle choices and core compliance considerations rather than step-by-step regulatory procedures. Always instruct local regulatory and legal counsel for jurisdiction-specific requirements.

Regulatory landscape and principal authorities

Pharmaceutical activities in Bangladesh are regulated through a combination of health ministries, drug regulatory authorities and professional regulators. Key functions to map early include licensing of premises and persons, product registration, import controls, manufacturing approvals and controlled-substances regulation. From a UK perspective, these areas intersect with manufacturing standards, product safety and cross-border trade controls.

• Product and manufacturing oversight: national drug regulator responsible for registration, quality control and Good Manufacturing Practice (GMP) standards.
• Professional regulation: licences and qualifications for pharmacists and responsible persons who may need to be physically present or registered with a national pharmacy council.
• Investment and corporate formalities: foreign-investment approvals and the choice of commercial vehicle affect licensing, taxation and local compliance obligations.

Business vehicles and commercial models

Foreign market entrants commonly consider a range of structures: a locally incorporated limited company, a joint venture with a domestic partner, distributor or franchise agreements, or establishing representative/branch offices for non-commercial presence. The chosen model will influence licensing pathways (manufacturing, wholesale, retail or import distribution) and whether local director/employee presence or local licence holders are required.

Key compliance and operational considerations

Operational and regulatory risk areas should be identified early and managed through contract and compliance design.

• Licensed personnel: many regimes require a registered pharmacist or responsible officer to be accountable for dispensing or distribution activities.
• Premises and storage: physical premises may need to meet prescribed standards for storage, dispensing and record-keeping.
• Controlled drugs and import/export: special permits and tighter controls apply to scheduled substances, with penalties for non-compliance.
• Quality and pharmacovigilance: post-market surveillance, adverse-event reporting and product traceability are increasingly enforced.
• Commercial contracts: procurement, distribution, agency and manufacturing agreements should allocate regulatory liabilities, recall obligations and IP protections.

Practical checklist for market entry

1. Map the regulatory regime against your intended activities (manufacture, import, wholesale, retail).
2. Decide the commercial vehicle and assess foreign investment or local ownership rules.
3. Confirm licensing and professional person requirements for each activity.
4. Undertake supplier and product due diligence: quality, registration and GMP status.
5. Plan logistics and customs compliance for importation and distribution.
6. Draft commercial agreements allocating regulatory and recall responsibilities.
7. Establish local compliance monitoring, training and document retention processes.
8. Engage local regulatory counsel and, where relevant, consultants for inspections and applications.

Jurisdiction and sources

For primary regulatory materials and official guidance consult the relevant national agencies and instruments, including the Directorate General of Drug Administration, the Pharmacy Council, the Ministry of Health and Family Welfare, the Bangladesh Investment Development Authority and the Companies Act and national drug policy texts. Seek certified translations and local legal interpretation where necessary.

TRW & Co’s London office at Holborn Gate, 330 High Holborn, London, WC1V 7QH can assist with cross-border structuring, supply-chain contracts and coordination with local advisers. This is a general overview aimed at international clients; it does not substitute for jurisdiction-specific legal or regulatory advice.

General information only; not legal advice and not a substitute for advice on a particular matter.